MxA protein assay for optimal monitoring of IFN-beta bioactivity in the treatment of MS patients.

Added 5358 days ago (18.12.2007)
Authors: Vallittu AM, Erälinna JP, Ilonen J, Salmi AA, Waris M
PubMed id: 18081914
Read article